Clear Harbor Asset Management, LLC Provention Bio, Inc. Transaction History

Clear Harbor Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	BUY	$4.52 - $10.57 $4,067 - $9,513	900 Added 5.14%	18,400 $0
Q3 2022 Oct 24, 2022	BUY	$3.43 - $5.62 $2,744 - $4,496	800 Added 4.79%	17,500 $79,000
Q4 2021 Jan 21, 2022	SELL	$5.59 - $7.39 $6,149 - $8,129	-1,100 Reduced 6.18%	16,700 $94,000
Q2 2021 Aug 06, 2021	BUY	$6.71 - $11.04 $6,039 - $9,936	900 Added 5.33%	17,800 $150,000
Q1 2021 Apr 14, 2021	BUY	$10.12 - $19.45 $6,071 - $11,670	600 Added 3.68%	16,900 $177,000
Q4 2020 Feb 04, 2021	BUY	$11.79 - $18.94 $3,536 - $5,682	300 Added 1.88%	16,300 $276,000
Q2 2020 Aug 05, 2020	BUY	$7.81 - $17.0 $3,905 - $8,500	500 Added 3.23%	16,000 $226,000
Q3 2019 Oct 31, 2019	BUY	$6.83 - $13.0 $105,865 - $201,500	15,500 New	15,500 $106,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.